148
Participants
Start Date
July 16, 2020
Primary Completion Date
September 30, 2023
Study Completion Date
November 30, 2023
Escitalopram
"Escitalopram, a selective serotonin reuptake inhibitor (SSRI), is commercially known as ELORYQA®, Elicea®, Escital®,PRAMES® or Lata® in Serbia. The recommended dose for Major depressive disorder is 10mg/day. Based on the individual response, dose can be adjusted and the maximum dose is 20 mg/day; 5 mg/day dose is also available. Escitalopram is also indicated for treatment of Obsessive-compulsive disorder, Generalized anxiety disorder, Social anxiety disorder (Social phobia) and Panic disorder (with or without agoraphobia) by Medicines and Medical Devices Agency of Serbia.~In known CYP2C19 poor metabolizers, initial dose should be 5mg/day during first 2 weeks, and based on the individual response it can be increased up to maximum of 10 mg of escitalopram per day, according to the guidelines of Medicines and Medical Devices Agency of Serbia."
RECRUITING
Clinical Centre of Serbia, Belgrade
NOT_YET_RECRUITING
Military Medical Academy, Belgrade
RECRUITING
Institute of Mental Health, Belgrade
Collaborators (1)
Clinical Centre of Serbia
OTHER
Institute of Mental Health, Serbia
UNKNOWN
Military Medical Academy, Belgrade, Serbia
OTHER
University of Belgrade
OTHER